Press release
Amylin Analogs Market: Strategic Analysis to Understand the Competitive Outlook of the Industry, 2025
Read Report Overview - https://www.transparencymarketresearch.com/amylin-analogs-market.html
Amylin is a 37 amino acid polypeptide neuroendocrine hormone that acts as an agent which provides the feeling of being full or fully satisfied by suppressing the intake of food, delays gastric emptying, regulates blood pressure with an effect on renin-angiotensin system, and inhibits glucagon secretion. In addition to the metabolic effects, human amylin may modulate innate inflammation, and autoimmunity via regulatory T cells to impact on both human type 2 and type 1 diabetes.
Diabetes is characterized by decreased secretion of insulin as well as amylin. Postprandial glucose control is assisted by amylin to insulin. In diabetes patients, the glucose or sugar is not converted to energy. This is due to insufficient production of insulin. Insulin helps in transfer of glucose from blood to the cells. Amylin helps regulate glucose appearance. Amylin analogs overcome the tendency of human amylin to aggregate, form insoluble particles, and adhere to surfaces. These help is reduction of body weight. Increase in prevalence of diabetes in both the developing as well as developed countries drives the global amylin analogs market.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39497
According to WHO, in 2016, there were 422 million people suffering with diabetes across the world. Rise in prevalence of diabetes is due to increase per capita income that leads to sedentary lifestyle, which is one of the primary causes of diabetes. Moreover, rise in prevalence of obesity is projected to drive the global amylin analogs market during the forecast period. Increase in inclination toward physical inactivity boosts demand for amylin analogs.
Rise in global geriatric population propels the amylin analogs market, as this population is more prone to diabetes. Advancements in amylin analogs boosts the growth of the global market. The global amylin analogs market can be segmented based on disease type, end-user, and region. In terms of disease type, the market can be categorized into type 1 diabetes and type 2 diabetes. Type 2 diabetes is estimated to dominate the market in 2016, owing to increased geriatric population across the world.
Get COVID-19 Analysis on Amylin Analogs Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=39497
Based on end-user, the global amylin analogs market can be classified into online pharmacies, retail pharmacies, and hospital pharmacies. The hospital pharmacies segment held the largest market share in 2016, owing to increased availability of amylin analog drugs in hospital pharmacies. The online pharmacies segment is anticipated to witness significant growth during the forecast period due to increase in adoption of ecommerce among the population.
Geographically, the global amylin analogs market can be segmented into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America held the largest market share in 2016 due to advancements in amylin analog drugs in the region. Europe is expected to account for the second largest market share in 2016, due to high disposable income, high research and development in health care, and compulsory medical insurance in countries such as Germany and France.
Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=39497
The market in Asia Pacific is anticipated to be driven by increase in government initiatives in health care, especially in China and India. The global amylin analogs market in Middle East & Africa is projected to experience strong growth during the forecast period due to increased disposable income especially in countries in the Middle East that leads to sedentary lifestyle which is responsible for diseases such as diabetes. The market in Latin America is anticipated to be driven by rise in government initiatives in health care.
Key players operating in the global amylin analogs market are Bristol-Myers Squibb and AstraZeneca.
More Trending Reports by Transparency Market Research -
Viral Vector & Plasmid DNA Manufacturing Market: https://www.prnewswire.com/news-releases/global-viral-vector--plasmid-dna-manufacturing-market-to-chart-23-3-cagr-from-2019-to-2027-transparency-market-research-301000176.html
Video Telemedicine Market: https://www.prnewswire.com/news-releases/hipaa-complaint-video-consultations-gain-patient-acceptance-video-telemedicine-market-to-garner-cagr-of-13-during-2020--2030-finds-tmr-301072555.html
Contact Us
Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Amylin Analogs Market: Strategic Analysis to Understand the Competitive Outlook of the Industry, 2025 here
News-ID: 2559194 • Views: …
More Releases from Transparency Market Research
Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 B …
The global gas compressor market was valued at US$ 23.2 Bn in 2025 and is projected to reach US$ 41.0 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. This steady growth trajectory reflects the structural importance of gas compression systems across upstream, midstream, and downstream gas value chains. Rising natural gas consumption, expansion of pipeline and LNG infrastructure, and national energy…
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Applicati …
The global anesthesia drugs market was valued at US$ 7.6 billion in 2025 and is projected to reach US$ 12.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2036. This steady growth trajectory reflects the essential and non-substitutable role of anesthesia drugs in modern healthcare systems. As surgical interventions continue to rise globally-across both elective and emergency procedures-the demand for safe, effective,…
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million t …
The global single-atom catalysts (SACs) market is poised for remarkable growth as industries seek highly efficient, cost-effective, and sustainable catalytic solutions. Valued at US$ 177.8 million in 2025, the market is projected to reach US$ 1,000.2 million by 2036, expanding at a robust compound annual growth rate (CAGR) of 17.0% from 2026 to 2036. This rapid expansion reflects the growing importance of advanced catalysis in energy, chemicals, environmental protection, and…
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported b …
The non-specific endonuclease market is witnessing steady growth, driven by the expanding use of molecular biology tools across biotechnology, pharmaceuticals, diagnostics, and academic research. Non-specific endonucleases are enzymes that cleave nucleic acids without requiring a specific recognition sequence, making them highly valuable for applications such as DNA/RNA degradation, sample preparation, viscosity reduction, and contamination control. Their broad activity profile differentiates them from restriction enzymes and enables versatile usage across multiple…
More Releases for Amylin
Europe Sustained Release Injectables Market Size, Share Report, Growing Demand t …
Sustained release injectables are a form of medication delivery designed to release a drug gradually over an extended period, often reducing the need for frequent dosing. These injectables are formulated to allow the drug to be absorbed slowly into the bloodstream, offering benefits like improved patient compliance, consistent therapeutic effects, and reduced side effects. They typically employ specialized mechanisms, such as biodegradable polymers, liposomes, or microencapsulation techniques, to control the…
GLP-1 Receptor Agonist Market See Incredible Growth 2024-2031 | Intarcia Therape …
GLP-1 Receptor Agonist Market Trends Overview 2024-2031:
A new Report by Coherent Market Insights, titled "GLP-1 Receptor Agonist Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the GLP-1 Receptor Agonist market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as…
GLP-1 Receptor Agonist Market Overall Study Report 2024-2031 | AstraZeneca, Inta …
GLP-1 Receptor Agonist Market Trends Overview 2024-2031:
A new Report by Coherent Market Insights, titled "GLP-1 Receptor Agonist Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the GLP-1 Receptor Agonist market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as…
HIV Associated Lipodystrophy Syndrome Market Scope and Opportunities Analysis 20 …
Global HIV Associated Lipodystrophy Syndrome Market: Snapshot
HIV-associated lipodystrophy is a syndrome that are found in human immune-deficiency virus (HIV)-infected patients who are being administered with active antiretroviral medications for the treatment of HIV infection. Patients have lipohypertrophy, an abnormal central fat accumulation or lipoatrophy, localized loss of fat tissue, or a mixed clinical presentations representing both. The complex morphological signs associated with lipodystrophy syndrome inhibits our understanding of the…
HIV Associated Lipodystrophy Syndrome Market | Alfa Wassermann S.P.A, Amylin Pha …
Global HIV Associated Lipodystrophy Syndrome Market: Overview
Human Immuno-deficiency Virus (HIV) presents itself as a complex mix of symptoms, which are related to severe immune compromise. Lipodystrophy is a condition, commonly associated with HIV patients globally, wherein there is a considerable loss of subcutaneous fat through the body. The increasing prevalence of lipodystrophy is the foremost factor driving the global market for HIV associated lipodystrophy syndrome. Continuous clinical advancements are…
Biorefinery Market Global Industry Analysis and Forecast to 2025 | Abengoa Bioen …
A bio refinery facilitates biomass conversion process, thereby producing power, chemicals and fuel among others from biomass with minimum emissions and waste. The core technology of this process is a distinctive thermal reactor which provides linear and sequential biomass fractionation through steam auto hydrolysis. The concept of bio refinery is similar to modern petroleum refinery that produces multiple products and fuel from petroleum. Moreover, bio refinery assists in production of…
